MNCs Vigorously Vie For Chinese Central Nervous System Drug Market
This article was originally published in PharmAsia News
Recent statistics show that in 2010, the 10 top anti-depressants had a combined 81.66% market share in hospitals.
You may also be interested in...
The combination of bupivacaine and meloxicam will be priced at a discount to Exparel, with Heron predicting rapid uptake. Label limited to three surgery types, but analysts expect off-label use.
Increasing number of product development meetings suggests that many complex generics remain in the development stages.
An expert panel at the recent AdvaMed Virtual Digital MedTech Conference discusses opportunities for medtech and consumer tech collaborations and how to make them successful.